Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q0RC
|
||||
Former ID |
DAP001119
|
||||
Drug Name |
Ethopropazine
|
||||
Synonyms |
Aethopropropazin; Athapropazine; Athopropazin; Ethapropazine; Ethopromazine; Etopropezina; Fempropazine; Fenpropazina; Isopthazine; Isotazin; Isothazine; Isothiazine; Lysivane; Parcidol; Pardidol; Parfezine; Parkin; Parkisol; Parsidan; Parsidol; Parsitan; Parsotil; Phenopropazine; Phenoprozine; Prodictazin; Prodierazine; Profenamina; Profenamine; Profenaminum; Prophenamine; Prophenaminum; Rochipel; Rocipel; Rodipal; Profenamina [Italian]; RP 3356; SC 2538; SKF 2538; W 483; Parkin (TN); Parsidan (TN); Parsidol(TN); Profenamina [INN-Spanish]; Profenamine (INN); Profenamine [INN:BAN]; Profenaminum [INN-Latin]; N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine; N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine; N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine; N,N-diethyl-1-(10H-phenothiazin-10-yl)propan-2-amine; 10-(2-Diethylaminopropyl)phenothiazine; 10-[2-(Diethylamino)-1-Propyl]phenothiazine;10-[2-(Diethylamino)-2-methylethyl]phenothiazine; 10-[2-(Diethylamino)propyl]phenothiazine; 2-Diethylamino-1-propyl-N-dibenzoparathiazine
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antiparkinson Agents
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H24N2S
|
||||
InChI |
InChI=1S/C19H24N2S/c1-4-20(5-2)15(3)14-21-16-10-6-8-12-18(16)22-19-13-9-7-11-17(19)21/h6-13,15H,4-5,14H2,1-3H3
|
||||
InChIKey |
CDOZDBSBBXSXLB-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 1094-08-2
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
5235096, 8152090, 10525152, 11335236, 11360475, 11363709, 11366271, 11368833, 11371338, 11374354, 11376995, 11455619, 11461447, 11466868, 11467988, 11484783, 11486456, 11488800, 11490245, 11492363, 11494629, 14923459, 29222428, 46507375, 46509734, 47365017, 47365018, 47959566, 48034942, 48110291, 48184832, 48334311, 48415977, 49698862, 50006444, 57244628, 57321707, 77111137, 85209984, 85505762, 87692421, 90341779, 96025112, 103362582, 104303077, 125672985, 126718928, 134338364, 134977403, 137138734
|
||||
SuperDrug ATC ID |
N04AA05
|
||||
SuperDrug CAS ID |
cas=000522009
|
||||
Target and Pathway | |||||
Target(s) | Histamine H1 receptor | Target Info | Modulator | [556264] | |
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References | |||||
Ref 536923 | Drugs used to treat Parkinson's disease, present status and future directions. CNS Neurol Disord Drug Targets. 2008 Oct;7(4):321-42. | ||||
Ref 542192 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7181). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.